Cargando…
Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation
INTRODUCTION: Small‐cell carcinoma of the prostate has a poor prognosis, and treatment options for the refractory disease are unclear. CASE PRESENTATION: A 68‐year‐old man with prostate cancer was referred to our hospital. He was treated with combined androgen blockade (bicalutamide and degarelix ac...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626344/ https://www.ncbi.nlm.nih.gov/pubmed/36341199 http://dx.doi.org/10.1002/iju5.12523 |